Zimmer Biomet

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$2,077,300
$1,909,100
$2,023,200
$1,824,200
Gross Profit
1,310,300
1,359,300
1,436,500
1,285,600
EBITDA
572,200
549,600
614,500
535,500
EBIT
300,400
295,200
350,900
284,600
Net Income
152,800
182,000
239,500
249,100
Net Change In Cash
2,077,300
1,909,100
2,023,200
1,824,200
Free Cash Flow
298,100
335,800
421,400
368,600
Cash
556,900
1,384,500
525,500
569,000
Basic Shares
198,300
199,700
199,900
203,000

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$7,678,600
$7,394,200
$6,939,900
$6,827,300
Gross Profit
5,487,400
5,310,400
4,920,400
4,866,900
EBITDA
2,250,900
2,214,300
2,212,600
2,160,100
EBIT
1,254,600
1,262,600
1,286,200
1,222,400
Net Income
903,800
1,024,000
231,400
401,600
Net Change In Cash
7,678,600
7,394,200
6,939,900
6,827,300
Cost of Revenue
58,500
-310,400
Free Cash Flow
1,142,600
1,187,100
1,096,800
1,347,200
Cash
525,500
415,800
375,700
378,100
Basic Shares
203,900
209,700
210,300
210,400

Earnings Calls

Quarter EPS
2025-06-30
$2.07
2025-03-31
$1.81
2024-12-31
$2.31
2024-09-30
$1.74